About Parexel
Parexel is a clinical research organization that provides clinical and consulting solutions to the life sciences industry. It works with biopharmaceutical leaders, emerging innovators, and clinical sites to design and deliver clinical trials, drawing on clinical, regulatory, and therapeutic expertise across global teams. Short and clear. Its work is described as covering the clinical development process from planning through execution, with an emphasis on patient-centered research and broadening access to clinical trials.
Founded in 1982 and based in Raleigh, North Carolina, Parexel has more than 22,000 employees globally. The company says it supports life sciences organizations in healthcare’s more complex therapeutic areas and operates with local knowledge combined with international reach. That is the focus. Its stated track record spans more than 40 years.
Need to reach the Parexel team directly? Find verified work emails for every employee with Snov.io
Insights
Updated 31 Aug 2026Parexel is carving out a position against other clinical research organizations by moving deeper into AI and specialized technology. The company launched ParexelAI to speed up clinical development, and it also expanded its patient safety technology through the acquisition of Vitrana, which points to a strategy built around innovation and operational support for sponsors. At the same time, it is broadening its presence in oncology and patient engagement through plans to present real-world oncology research and launch a new patient-focused campaign at ASCO 2026.
The sources point to a strategic shift toward embedding technology across the trial lifecycle. That includes faster clinical development, stronger patient safety, and more use of real-world evidence, while Parexel’s recent newsroom activity focuses on product and capability expansion rather than financial disclosures, suggesting the company is using partnerships, acquisitions, and new AI tools to reinforce its service offering and market relevance.
For investor and consumer signals, the supplied sources mostly show company-led momentum rather than external funding or earnings data. Repeated announcements around AI, acquisition, awards, and conference presence suggest active commercial signaling and an emphasis on innovation-led growth. No funding round, hiring surge, or earnings update is provided in the sources.
Frequently asked questions
Parexel is headquartered in Raleigh, North Carolina, United States.
Parexel has 10001+ employees according to its company profile.
Parexel operates in the Pharmaceuticals sector. Public valuation figures are not always disclosed for private companies.